What's breaking now, across thousands of outlets.
Scientific Reports, Published online: 24 October 2026; doi:10.1038/s41598-026-77952-1 Development and validation of a postoperative prognostic nomogram for early-stage pancreatic cancer
We haven't written up this one. Scientific Reports has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
AstraZeneca has begun selling a Chinese-developed lung cancer drug in the U.S. that some American patients had been flying to China to buy.
[UN News] As Ebola continues to spread in the Democratic Republic of the Congo (DRC), more resources are needed to fight the disease and feed patients and families, UN agencies said on Friday.
Pancreatic cancer is one of the most aggressive and difficult-to-treat cancers. One reason for its resistance to therapy is the dense tissue surrounding the tumor that acts as a protective barrier and…
As Nigeria approaches the 2027 general elections, concerns surrounding Ebola raise an important national question: Can Nigeria effectively manage a public health emergency without compromising its…
The outbreak response has been hampered by the lack of approved treatments for the Bundibugyo strain, with the Ervebo vaccine to be tested for potential cross-protection.
The outbreak response has been hampered by the lack of approved treatments for the Bundibugyo strain, with the Ervebo vaccine to be tested for potential cross-protection.
